|
The Immunohistochemistry Antibody Company
|
- Home
-
Products
- All Antibodies
- IHC-plus Antibodies
-
Services
- Immunohistochemistry Studies
- Tissue Cross-Reactivity Screening
- Distributors
-
Resources
- About our Tissue Bank
- Customer Support
- How to Buy
- IHC-plus Protocol
- LSBio Media
- Publications
- Antibody Reports
-
Company
- About LifeSpan
- Press Releases
- Holiday Schedule
- Contact Us
|
|
General Cancer Screen 90 Tissue Microarray - LS-SCA90
This tissue microarray is available for use in LSBio Immunohistochemistry Studies only.
|
|
| Catalog ID: |
LS-SCA90 |
| Product Name: |
General Cancer Screen 90 |
| Description: |
7 different normal tissue types and 5 major tumor types with stage/grade (duplicate cores) |
| Format: |
FFPE |
| Category: |
Human Multi-Tumor and Normal |
| QA/QC: |
H&E reviewed; IHC validated with a positive control antibody |
| Storage: |
Short term RT; Long term 4ºC |
| Clinical History: |
No |
| Tissue Marker: |
No |
| Stage/Grade: |
Yes |
| Core Diameter: |
1.5 mm |
| Core Thickness: |
4 µm |
| Cases: |
12 |
| Cores: |
24 |
| Slides Per Set: |
1 |
LS-SCA90 Tissue Microarray Map
Slide Number 1
| LABEL | | | 1 | 2 | 3 | 4 | 5 | 6 | | A | Brn | Bst | Col | Liv | Lng | Pst | | B | Brn | Bst | Col | Liv | Lng | Pst | | C | Tsl | Bst | Col | Liv | Lng | Pst | | D | Tsl | Bst | Col | Liv | Lng | Pst |
|
Diagnosis Type Legend| Benign non-neoplastic | Diseased | Inflammatory | Malignant | Metastatic | Tumor | Unknown |
Element Tissue LegendBrain, Cerebral cortex (Brn); Breast (Bst); Colon (Col); Liver (Liv); Lung (Lng); Prostate (Pst); Tonsil (Tsl);
LS-SCA90 Element Details
| Slide | Position | Species | Gender | Age | Tissue | Diagnosis | Diagnosis Type | TNM Tumor Classification | Tumor Stage |
|---|
| 1 | A1 | Human | M | 46 y | Brain, Cerebral cortex (Brn) | Normal | Benign non-neoplastic | | |
| 1 | A2 | Human | F | 39 y | Breast (Bst) | Normal with hyperplasia | Diseased | | |
| 1 | A3 | Human | M | 68 y | Colon (Col) | Normal | Benign non-neoplastic | | |
| 1 | A4 | Human | M | 52 y | Liver (Liv) | Normal with cell swelling | Diseased | | |
| 1 | A5 | Human | M | 47 y | Lung (Lng) | Normal | Benign non-neoplastic | | |
| 1 | A6 | Human | M | 74 y | Prostate (Pst) | Normal with hyperplasia | Diseased | | |
| 1 | B1 | Human | M | 46 y | Brain, Cerebral cortex (Brn) | Normal | Benign non-neoplastic | | |
| 1 | B2 | Human | F | 39 y | Breast (Bst) | Normal with hyperplasia | Diseased | | |
| 1 | B3 | Human | M | 68 y | Colon (Col) | Normal | Benign non-neoplastic | | |
| 1 | B4 | Human | M | 52 y | Liver (Liv) | Normal with cell swelling | Diseased | | |
| 1 | B5 | Human | M | 47 y | Lung (Lng) | Normal | Benign non-neoplastic | | |
| 1 | B6 | Human | M | 74 y | Prostate (Pst) | Normal with hyperplasia | Diseased | | |
| 1 | C1 | Human | M | 25 y | Tonsil (Tsl) | Normal | Benign non-neoplastic | | |
| 1 | C2 | Human | F | 63 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | T2N2M0 | II-III |
| 1 | C3 | Human | M | 51 y | Colon (Col) | Carcinoma | Malignant | T3N0M0 | I-II |
| 1 | C4 | Human | M | 65 y | Liver (Liv) | Hepatocellular carcinoma | Malignant | T2N0M0 | II-III |
| 1 | C5 | Human | M | 55 y | Lung (Lng) | Squamous cell carcinoma | Malignant | T2N0M0 | II |
| 1 | C6 | Human | M | 47 y | Prostate (Pst) | Adenocarcinoma | Malignant | T2N0M0 | II |
| 1 | D1 | Human | M | 25 y | Tonsil (Tsl) | Normal | Benign non-neoplastic | | |
| 1 | D2 | Human | F | 63 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | T2N2M0 | II-III |
| 1 | D3 | Human | M | 51 y | Colon (Col) | Carcinoma | Malignant | T3N0M0 | I-II |
| 1 | D4 | Human | M | 65 y | Liver (Liv) | Hepatocellular carcinoma | Malignant | T2N0M0 | II-III |
| 1 | D5 | Human | M | 55 y | Lung (Lng) | Squamous cell carcinoma | Malignant | T2N0M0 | II |
| 1 | D6 | Human | M | 47 y | Prostate (Pst) | Adenocarcinoma | Malignant | T2N0M0 | II |
Copyright © 2013 LifeSpan BioSciences, Inc. All Rights Reserved
